These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21147213)

  • 101. Foxp3 expression is required for the induction of therapeutic tissue tolerance.
    Regateiro FS; Chen Y; Kendal AR; Hilbrands R; Adams E; Cobbold SP; Ma J; Andersen KG; Betz AG; Zhang M; Madhiwalla S; Roberts B; Waldmann H; Nolan KF; Howie D
    J Immunol; 2012 Oct; 189(8):3947-56. PubMed ID: 22988034
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Isolation and in vitro Expansion of Regulatory T Cells from β-Thalassemia Major Kids and in vitro Evaluation of Their Plasticity and Inhibitory Effects in the Presence of Pro-Inflammatory Cytokines.
    Mansourabadi AH; Mohamed Khosroshahi L; Noorbakhsh F; Hamidieh AA; Amirzargar A
    Int Arch Allergy Immunol; 2023; 184(1):63-75. PubMed ID: 36265456
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cells.
    Castiello L; Mossoba M; Viterbo A; Sabatino M; Fellowes V; Foley JE; Winterton M; Halverson DC; Civini S; Jin P; Fowler DH; Stroncek DF
    Cytotherapy; 2013 May; 15(5):598-609. PubMed ID: 23352462
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Defective CD8+CD28+ regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy.
    Ceeraz S; Hall C; Choy EH; Spencer J; Corrigall VM
    Clin Exp Immunol; 2013 Oct; 174(1):18-26. PubMed ID: 23786396
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4(+)CD25(+)FOXP3(+) T regulatory cell subpopulations.
    Scottà C; Esposito M; Fazekasova H; Fanelli G; Edozie FC; Ali N; Xiao F; Peakman M; Afzali B; Sagoo P; Lechler RI; Lombardi G
    Haematologica; 2013 Aug; 98(8):1291-9. PubMed ID: 23242600
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Modulation and recruitment of inducible regulatory T cells by first trimester trophoblast cells.
    Ramhorst R; Fraccaroli L; Aldo P; Alvero AB; Cardenas I; Leirós CP; Mor G
    Am J Reprod Immunol; 2012 Jan; 67(1):17-27. PubMed ID: 21819477
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Rapamycin-resistant effector T-cell therapy.
    Fowler DH
    Immunol Rev; 2014 Jan; 257(1):210-25. PubMed ID: 24329799
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Novel Humanized Peripheral Blood Mononuclear Cell Mouse Model with Delayed Onset of Graft-versus-Host Disease for Preclinical HIV Research.
    Holguin L; Echavarria L; Burnett JC
    J Virol; 2022 Feb; 96(3):e0139421. PubMed ID: 34818071
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Recombinant Pregnancy-Specific Glycoprotein 1 Has a Protective Role in a Murine Model of Acute Graft-versus-Host Disease.
    Jones K; Bryant S; Luo J; Kiesler P; Koontz S; Warren J; Malech H; Kang E; Dveksler G
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):193-203. PubMed ID: 30253241
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Controlled release formulations of IL-2, TGF-β1 and rapamycin for the induction of regulatory T cells.
    Jhunjhunwala S; Balmert SC; Raimondi G; Dons E; Nichols EE; Thomson AW; Little SR
    J Control Release; 2012 Apr; 159(1):78-84. PubMed ID: 22285546
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly.
    Veerapathran A; Pidala J; Beato F; Yu XZ; Anasetti C
    Blood; 2011 Nov; 118(20):5671-80. PubMed ID: 21948174
    [TBL] [Abstract][Full Text] [Related]  

  • 112. In vitro induction of regulatory CD4+CD8α+ T cells by TGF-β, IL-7 and IFN-γ.
    Van Kaer L; Rabacal WA; Scott Algood HM; Parekh VV; Olivares-Villagómez D
    PLoS One; 2013; 8(7):e67821. PubMed ID: 23844100
    [TBL] [Abstract][Full Text] [Related]  

  • 113. The effect of foxp3-overexpressing Treg cells on non-small cell lung cancer cells.
    Peng J; Yu Z; Xue L; Wang J; Li J; Liu D; Yang Q; Lin Y
    Mol Med Rep; 2018 Apr; 17(4):5860-5868. PubMed ID: 29436663
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Long-term engraftment of human natural T regulatory cells in NOD/SCID IL2rγc(null) mice by expression of human IL-2.
    Abraham S; Pahwa R; Ye C; Choi JG; Pahwa S; Jaggaiahgari S; Raut A; Chen S; Manjunath N; Shankar P
    PLoS One; 2012; 7(12):e51832. PubMed ID: 23272176
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Pan-Bcl-2 inhibitor, GX15-070 (obatoclax), decreases human T regulatory lymphocytes while preserving effector T lymphocytes: a rationale for its use in combination immunotherapy.
    Kim PS; Jochems C; Grenga I; Donahue RN; Tsang KY; Gulley JL; Schlom J; Farsaci B
    J Immunol; 2014 Mar; 192(6):2622-33. PubMed ID: 24516200
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex.
    King MA; Covassin L; Brehm MA; Racki W; Pearson T; Leif J; Laning J; Fodor W; Foreman O; Burzenski L; Chase TH; Gott B; Rossini AA; Bortell R; Shultz LD; Greiner DL
    Clin Exp Immunol; 2009 Jul; 157(1):104-18. PubMed ID: 19659776
    [TBL] [Abstract][Full Text] [Related]  

  • 117. All-trans retinoic acid and rapamycin synergize with transforming growth factor-β1 to induce regulatory T cells but confer different migratory capacities.
    Jhunjhunwala S; Chen LC; Nichols EE; Thomson AW; Raimondi G; Little SR
    J Leukoc Biol; 2013 Nov; 94(5):981-9. PubMed ID: 23898044
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease.
    Veerapathran A; Pidala J; Beato F; Betts B; Kim J; Turner JG; Hellerstein MK; Yu XZ; Janssen W; Anasetti C
    Blood; 2013 Sep; 122(13):2251-61. PubMed ID: 23908471
    [TBL] [Abstract][Full Text] [Related]  

  • 119. TGF-β-induced CD4+Foxp3+ T cells attenuate acute graft-versus-host disease by suppressing expansion and killing of effector CD8+ cells.
    Gu J; Lu L; Chen M; Xu L; Lan Q; Li Q; Liu Z; Chen G; Wang P; Wang X; Brand D; Olsen N; Zheng SG
    J Immunol; 2014 Oct; 193(7):3388-97. PubMed ID: 25156367
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD.
    Haase D; Starke M; Puan KJ; Lai TS; Rotzschke O
    Immunol Res; 2012 Sep; 53(1-3):200-12. PubMed ID: 22418725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.